The S100A9 gene helps make a protein used by certain white blood cells to sense infection, signal tissue damage, and guide inflammation. This gene plays an important role in your body’s early immune response, often by pairing with the S100A8 protein to form calprotectin. If it does not work as expected, inflammatory signals may become unbalanced, which can affect how the body responds to germs or injury. Changes in S100A9 activity are also linked with inflammatory conditions, and calprotectin made from this pathway is commonly measured in stool or blood tests.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or guide activities throughout the body. Some genes provide the code for proteins, which do much of the cell’s work. Others mainly regulate when certain processes happen, where they happen, and how active they are. Taken together, genes affect how the body develops and functions, and they can influence how you respond to food, stress, and medications. For a deeper look at this topic, you can learn more in the LearnHub.
Overview
S100A9Gene function
What if the gene works
The S100A9 gene helps certain white blood cells control inflammation and respond to infection. Its protein also binds minerals such as calcium and zinc, which supports immune signaling and helps protect tissues during injury.
Risk
What if the gene does not work
Milder variants in the S100A9 gene may slightly alter immune cell signaling, while more severe variants can sharply reduce the S100A9 protein. This can weaken its usual pairing with S100A8 and disrupt calcium controlled signaling inside immune cells.
Treatment
What does that mean for your treatment
No treatment or drug choice based specifically on a pathogenic or loss-of-function variant in the S100A9 gene is currently established. The S100A9 gene is also being studied as an inflammation biomarker and possible drug target, especially in cancer and inflammatory conditions.
Gene function
What if the gene works
In your immune system, the S100A9 gene helps white blood cells respond to infection and tissue stress. Its protein is especially active in early response cells such as neutrophils and monocytes. This steady day to day work supports inflammation control, germ defense, and immune cell movement.
The S100A9 gene helps white blood cells adjust inflammation signals when the body senses infection or tissue stress. Its protein can also be released outside cells, where it alerts nearby immune cells and helps coordinate an early response.
Together with the S100A8 protein, it forms calprotectin, a protein pair used in frontline immune defense. This pair can hold onto zinc and manganese, which can make it harder for many bacteria and fungi to grow.
Inside white blood cells, the S100A9 protein helps organize the shape changes needed to reach a problem area. This supports how these cells stick, move through blood vessel walls, and gather where they are needed.
The S100A9 protein binds calcium, which helps switch its activity on at the right time. That calcium sensing changes how it interacts with partner proteins and supports how the S100A9 gene affects inflammation in the body.
What is a variant?
A genetic variant is a minor change in the DNA sequence of a gene. These changes are common and help shape normal human diversity, including differences in appearance, metabolism, or the way the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can more substantially change how a gene functions and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the S100A9 gene can change how much S100A9 protein a cell makes or alter its shape, which may weaken calcium or zinc binding, reduce stability, or disrupt pairing with its partner S100A8. This is how variants influence the S100A9 gene's function at the cellular level. Milder variants may leave some protein activity intact, while more severe variants can markedly lower protein production or create a shortened protein that works poorly or is quickly broken down.
How variants are linked to conditions
Current research on how S100A9 gene variants are linked to conditions is still developing. The S100A9 gene does not yet have a broadly confirmed link to a specific health condition, and this may change as more human studies are completed. Anyone with a confirmed variant in the S100A9 gene should rely on guidance from their doctor or genetic counselor for personal interpretation.
A variant is not necessarily a diagnosis
Gene variants are a usual part of human biology and are widely seen in the general population. Most do not directly affect health and instead reflect normal human diversity. For many genes, having a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors also contribute. In some situations, though, a single well characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk specifically related to the S100A9 gene. S100A9 can be involved in inflammation, but personal risk usually depends on many genes, overall health, and everyday factors, so anyone concerned about inherited risk should speak with a doctor or genetic counselor.
Inheritance of S100A9 variants
There is not yet a broadly confirmed Mendelian pattern for how S100A9 gene variants are inherited in relation to a specific inherited condition. Most findings about the S100A9 gene involve risk or susceptibility rather than a clearly defined single-gene syndrome, so how S100A9 gene variants are inherited is not described as autosomal dominant, autosomal recessive, or X-linked for an established disease. The S100A9 gene is located on chromosome 1, which is an autosome, so each person inherits one copy from each parent.
What does my S100A9 result mean for my family?
There is not yet a broadly confirmed inherited pattern tying S100A9 changes to one specific genetic condition in the way seen with classic single-gene conditions. If you have an S100A9 result and want to know what it could mean for relatives, a doctor or genetic counselor can explain it in the context of your exact result and family history.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a variant in the S100A9 gene, a lab can study DNA from a saliva sample or blood test. S100A9 genetic testing reads the gene's code and compares it with the usual sequence to identify variants. Results may show a benign change, a variant of uncertain significance, or a variant linked to disease risk.
When should I consider getting a genetic test?
There is not yet a broadly established, S100A9-specific reason for genetic testing in routine care. Decisions about testing are usually based on your personal health history, family history, and the broader condition a doctor or genetic counselor is looking into.
A genetic result is only one part of your health story
A genetic finding can provide useful insight, yet how much it explains depends on the condition and on the kind of variant involved. Over time, many factors, including lifestyle, environment, age, and medical history, affect how the body functions. For some conditions, especially those shaped by many genes, genetic information offers context rather than certainty and is most useful when considered alongside other parts of care. In other situations, a genetic result can give a clear answer. In areas such as medication response, genetic results can also help place personal experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in genes can change how the body breaks down a drug, moves it through the bloodstream, or responds to it at its target. This is common and can help explain why the same treatment works well for one person, works less well for another, or causes more side effects in someone who is more sensitive to it.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in genes can affect a person’s response to medications. By studying connections between genes and drugs, it helps explain why the same treatment may work differently from one person to another. For many medicines, genes influence how the body handles a drug or how strong its effects are. This information can support more informed and individualized treatment decisions. More about this topic is available in the LearnHub.
Drugs influenced by the S100A9 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choices, so general questions about side effects, new symptoms, or how well a treatment is working are best discussed with your doctor. Research on the S100A9 gene is exploring links with inflammation and response to some cancer and immune treatments, but this is not yet used routinely in care.
History
The S100A9 gene entered the medical literature as researchers mapped the growing S100 family of genes involved in inflammation. Initially understood only through visible traits, later recognized as tied to a specific gene, S100A9 was identified in white blood cells and studied alongside the closely related S100A8 gene. Over time, descriptions became more precise, especially after the S100A8 and S100A9 proteins were recognized together as calprotectin, a marker that became widely used in inflammatory bowel disease and other inflammatory conditions. This work helped move S100A9 from a laboratory finding to a clinically useful part of modern testing. In recent decades, its role in inflammation and immune signaling has become a steady focus of research.